chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse (RN) concerning a 13 year old male, with no pertinent medical history, drug reactions or allergies, who on 02-FEB-1995 was vaccinated with VARIVAX (Merck). On approximately 18-DEC-2006 the patient complained of a sore throat, fever, rash and small papules on his face, back and chest. Some of the papules were open, but none were fluid filled. The physician diagnosed the patient with mild case of chickenpox. There was no concomitant therapy. The final outcome was unknown at the time of this report. Unspecified medical attention was sought. There was no product quality complaint. There wwere no lab diagnostic studies performed. Additional information has been requested.  No further information is expected.
Patient was complaining of being really hot & dizzy. His eyes rolled and he lost consciousness for a few seconds. He was pale and diaphoretic. Made some chocking sounds. Denied any swelling of the throat or tongue. He was lowered to the ground and ice packs applied under his arms. 911 was dispatched and the medics came to attend.
1st shot: No reaction 2nd shot: 12 hours after vaccine got reactions.  Went to bed feeling fine.     Felt hot and burning inside mouth.  Severe pain for 1 week.  vicodin helped a little.     Residual numbness and pain - inside of skin.  But no residual symptoms now (10/13/2021).   Before 1st vaccine - had spot in mouth.  Had biopsy 2 days after 2nd vaccine - diagnosed with lichen planus in mouth -    biopsy scheduled and done 2 days after COVID vaccine.   Given steroid gel - helped some.
The symptoms I have with MS, intensified for about a week. As of right now I am back to Baseline. My next shot is on March 20th and It will be interesting to see if the same intensity happens.
Reactivation of Herpes Zoster (Shingles) Day 7 post vax - nerve pain & burning on lower torso & right flank started; continued several days Day 14 post vax - Shingles rash appeared on lower abdomen, right hip & backside; pain Treatment:  Valacyclovir HCl, 1 gm, 3x daily for 10 days  Gabapentin 300 mg, 1x daily for 30 days  Lingering symptoms of shingles is continuing, including numbness, itching, other
Dizziness; Stomach aches; Headache; Nausea; Fever which ranged from 103.8-104.5F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Stomach aches), HEADACHE (Headache), NAUSEA (Nausea) and PYREXIA (Fever which ranged from 103.8-104.5F) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced DIZZINESS (Dizziness), ABDOMINAL PAIN UPPER (Stomach aches), HEADACHE (Headache), NAUSEA (Nausea), PYREXIA (Fever which ranged from 103.8-104.5F) and CHILLS (Chills). At the time of the report, DIZZINESS (Dizziness) and NAUSEA (Nausea) had not resolved and ABDOMINAL PAIN UPPER (Stomach aches), HEADACHE (Headache), PYREXIA (Fever which ranged from 103.8-104.5F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, Body temperature: ranged from 103.8-104.5 f (abnormal) Ranged from 103.8-104.5 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Experienced dizziness about 5 minutes after getting the vaccine.  Not feeling well the same evening due to stomach aches, dizziness, headache, and she could not get out of bed the next day. Concomitant medication use not reported. Treatment: Acetaminophen (TYLENOL) and ibuprofen which did not break the fever.
Fever up to 103.4; chills; body aches; nausea; rash on neck and left arm.   Treated with extra strength Tylenol and Benadryl.  Fever lasted approximately 12 hours.  Rash on neck and arm appeared 36 hours after shot and still remains at the time of this report.
I developed fever (102 F) chills, muscle aches, and extreme fatigue. The fever has subsided. The muscle aches and fatigue are still occurring. I did have a confirmed COVID infection in March 2020.
Patient was alert cooperative and breathing comfortably multiple blanching, non-tender erythematous maculopapular lesions all over the face, neck, behind the ears, trunk and extremities. No enlarged tonsils. Regular heart rate rhythm no murmurs.
Patient came to ED with worsening shortness of breath and was admitted with Covid-19 pneumonia, hypoxia, and NSTEMI.
17 year old previously healthy male admitted for presumed myocarditis.      He reports that three days ago he started to feel ill with decreased appetite and fatigue. He came home from school Thursday and slept for the afternoon. Friday he continued to feel poorly.  Yesterday afternoon he presented to the ED  with symptoms of fever, fatigue and constipation. He was treated, discharged home, and his abdominal pain resolved. Later yesterday evening he presented to the  ED with  acute onset of chest pain and SOB, with chest pain with deep breaths. He was treated and evaluated with IV fluids, Ketoralac, lorazepam, nitroglycerin, and aspirin. Labs, and xray completed and significant for negative COVID 19, Troponin 0.42, with repeat at 0.51.  Sed rate normal at 2, CRP elevated at 5.39, BNP normal at 110. EKG showed rate 69, regular intervals, NAD, Non specific ST abnormality, no STEMI.  He was diagnosed with myocarditis and was transported by med flight to our ED this morning.   Of note, he has received COVID Pfizer series (LOT unknown), vaccines in April 2021,and had COVID infection in Oct 2020. He took an antibiotic for a tick bite last year and had one tick crawling on him this spring. Otherwise, denies any known exposures to insect bites, no recent travel, no trauma.
Information has been received from a pharmacist regarding to a patient of unknown age and gender. On 20-AUG-2012, the patient was vaccinated with a dose of ZOSTAVAX, (lot # 672932/0599AE, expiration date 22-JUN-2013). No other co-suspects were reported. No concomitant medications were reported. It was reported that after received ZOSTAVAX, the patient had redness and a raised bump around the injection site. The patient did not receive treatment for the adverse event. The patient did not recover from the adverse events. This is one of several reports from the same source. Additional information has been requested.
loud tinnitus; difficult to concentrate; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 21Sep2022 at 11:00 as dose 5 (booster), single (Lot number: 5342) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "hypothyroid." (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; VALSARTAN. Past drug history included: Cipro, reaction(s): "Known allergies: Cipro"; Azithromycin, reaction(s): "Known allergies: azithromycin"; Protonix, reaction(s): "Known allergies: protonix". Vaccination history included: BNT162b2 (Dose 4, single, Batch/Lot No: 9896, location of injection: Arm Left), administration date: 02Apr2022, when the patient was 62-year-old, for Covid-19 Immunization, reaction(s): "Loud tinnitus/noise in ears", "difficult to concentrate"; BNT162b2 (Dose 3, single, Batch/Lot No: 8028, location of injection: Arm Left), administration date: 04Nov2021, when the patient was 61-year-old, for Covid-19 Immunization, reaction(s): "Loud tinnitus/noise in ears", "difficult to concentrate"; BNT162b2 (Dose 2, single, Batch/Lot No: EN6208, location of injection: Arm Left), administration date: 15Mar2021, when the patient was 61-year-old, for Covid-19 Immunization; BNT162b2 (Dose 1, single, Batch/Lot No: EL9266, location of injection: Arm Left), administration date: 22Feb2021, when the patient was 60-year-old, for Covid-19 Immunization. The following information was reported: DISTURBANCE IN ATTENTION (non-serious) with onset Sep2022, outcome "not recovered", described as "difficult to concentrate"; TINNITUS (non-serious) with onset Sep2022, outcome "not recovered", described as "loud tinnitus". Therapeutic measures were not taken as a result of tinnitus, disturbance in attention. Additional information: The patient experienced prolonged (lasting several weeks) episodes of loud tinnitus after each booster and her recent omicron booster. The noise in both her ears was intrusive and annoying, making it very difficult to concentrate. The patient had no COVID prior vaccination and did not have COVID test post vaccination.
pt recv vax & w/in approx 2-3 days devel metabolic acidosis & dec level of consciousness;pt was hosp;unspecified test have been negative;
1/17/21 at 1:30pm- Nausea and vomitting lasting several hours 1/18/21: aching, chills, fatigue, swollen lymph nodes  1/19/21:  decreased sense of taste/smell
Information regarding PREVNAR 13 was received from a healthcare professional regarding a male patient who experienced that he didn't do well. The patient received a dose in 2010. The patient experienced that he didn't do well in 2010. The reporter explained that this patient is not a patient of this medical office and that she had no additional information other than what has been provided.
Patient reported that her body did not build antibodies after receiving the vaccine; This spontaneous case was reported by a health care professional and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (Patient reported that her body did not build antibodies after receiving the vaccine) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (Patient reported that her body did not build antibodies after receiving the vaccine). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (Patient reported that her body did not build antibodies after receiving the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment product details not provided.  Concomitant product details not provided.
given total of 1.65 ml instead of 0.5ml; tingling on her mouth; feeling tingling ears/Cheeks; feeling of numbness mouth; feeling of numbness ears/Cheeks; pain; chills; muscle aches; This spontaneous case was reported by a patient and describes the occurrence of ACCIDENTAL OVERDOSE (given total of 1.65 ml instead of 0.5ml), PARAESTHESIA ORAL (tingling on her mouth), PARAESTHESIA (feeling tingling ears/Cheeks), HYPOAESTHESIA ORAL (feeling of numbness mouth) and HYPOAESTHESIA (feeling of numbness ears/Cheeks) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Seasonal allergy, Drug allergy (Sulfa), Penicillin allergy and Drug allergy (Emgality). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRETIC), FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and AZELASTINE for Allergy, NADOLOL, TOPIRAMATE (TOPAMAX), UBROGEPANT (UBRELVY) and SUMATRIPTAN for Migraine.    On 19-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1.65 ml. On 19-May-2021, the patient experienced ACCIDENTAL OVERDOSE (given total of 1.65 ml instead of 0.5ml), PARAESTHESIA ORAL (tingling on her mouth), PARAESTHESIA (feeling tingling ears/Cheeks), HYPOAESTHESIA ORAL (feeling of numbness mouth), HYPOAESTHESIA (feeling of numbness ears/Cheeks), PAIN (pain), CHILLS (chills) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) for Chills and Ache, at a dose of 1 dosage form and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) at an unspecified dose and frequency. At the time of the report, ACCIDENTAL OVERDOSE (given total of 1.65 ml instead of 0.5ml), PARAESTHESIA ORAL (tingling on her mouth), PARAESTHESIA (feeling tingling ears/Cheeks), HYPOAESTHESIA ORAL (feeling of numbness mouth), HYPOAESTHESIA (feeling of numbness ears/Cheeks), PAIN (pain), CHILLS (chills) and MYALGIA (muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information provided
No adverse reactions. Patient received 2 different doses (Moderna as the first dose and Pfizer as the second dose).
Significant drowsiness began the morning after receiving the vaccine. I was unable to sustain a normal level of activity and slept for more than half of the usual waking hours.
Felt like joints were hurting; Had pain form left armpit to wrist; Blotchy skin began on 01MAR18, in the upper arm area where injection was given; Patient characterized as looks like liver spots; This is a non-serious spontaneous case, initially received from pharmacist on 02-Mar-2018, concerning a 77-year-old, elderly, male patient.  The patient's medical history and concomitant medications were not reported.  On 07-Feb-2018, the patient was administered with Afluria Quadrivalent (influenza vaccine, dose; 0.5 ml, route of administration: intramuscular, anatomical location: left deltoid, batch number and expiry date: not reported) for an unknown indication.  On 01-Mar-2018, after 23 days of vaccination, the patient developed blotchy skin in upper arm, where injection was given (skin blotches) which looked like as liver spots. On an unspecified date, the patient had joint pain and pain from left armpit to his wrist (pain in arm).   At the time of this report, the patient had recovered from the events.  Follow-up report received from pharmacist on 28-Mar-2018: The date of birth and the age of the patient was updated. The outcome (recovered) for all the events was updated. Narrative amended accordingly.; Reporter's Comments: A 77-year-old, male patient, developed skin blotches, liver spots after 23 days of vaccination, joint pain and pain in arm on an unspecified date after the vaccination, company assess the events skin blotches, liver spots as not related due to long onset latency and joint pain, pain in arm as unassessable due to unknown onset latency.
First Dose: dizzy, tired Second dose: headache, fever, aches, tired, rash
arm pain; unable to use arm; This spontaneous report was received from a nurse practitioner referring to a 43-year-old female patient. The patient had no pertinent medical history, or drug reactions or allergies. Concomitant medications included desogestrel, rizatriptan benzoate (MAXALT), spironolactone (ALDACTONE) and escitalopram oxalate (LEXAPRO).  On 09-AUG-2022, the patient was vaccinated with HPV rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection (lot # 1775827, expiration date was 27-JUN-2024, serial number was reported as 17006-4121-01; strength and dose were not reported) administered intramuscularly through left deltoid for prophylaxis. The patient had previously vaccinated 2 doses.  On 12-AUG-2022, the patient had presented with arm pain, and she was having a hard time using arm because of pain. The arm pain had persisted for more than 2 weeks. Lab/diagnostic tests were not performed. The reporter was unable to confirm if the patient was administered ibuprofen prior to or at current call time. The outcome of the events was reported as unknown.   The causality between the events and the suspect vaccine was reported as related.
Following administration of her second COVID vaccine she noted sharp, sudden pains that moved from her L shoulder up the face. She reported that the pain was improved but 8 months after the vaccine. (12/21) she reported to a provider that she had limited range of motion of the shoulder.  Normal XR of the L shoulder and C-spine. MRI pending but patient does not have insurance and cannot afford this imaging. It was originally documented to be placed in the right shoulder, though please note that patient is complaining of left shoulder pain. She was referred to physical therapy 1/22.
Myalgia, NauseaVomiting, CHILLS; JITTERY Narrative:
PANIC; NOT THE SAME PERSON MENTALLY SPEAKING; DREAMS OF DEAD; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced panic, not the same person mentally speaking, and dreams of dead. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the panic, not the same person mentally speaking and dreams of dead was not reported. This report was non-serious. This report was associated with product quality complaint: 90000254615
I've had all of the commonly listed side effects (pain at injection site, headache, nausea, muscle soreness, chills, sweats, extreme fatigue). The only abnormality is that they're still present five days later with only mild improvement. The nausea was gone after one day, but I'm still struggling with fatigue, sweats and occasional chills.
Moderna COVID-19 Vaccine EUA Tired - lasted about 24 hours Severe headache - lasted about 18 hours - tylenol Cold like symptoms - lasted about 3 days Pain and bump at injection site - lasted about 3 days Entire arm was sore and painful to use - started about 4 hours after injection, lasted about 24 hours
This spontaneous report as received from a licensed practical nurse refers to a patient of an unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of GARDASIL 0.5 ml, intramuscularly, lot # L035105 with expiration date: 14-MAY-2017 (dose number was unknown). Administered dose of GARDASIL was exposed to a temperature of 1.2 degrees Celsius, for 12 hours. Data logger was involved. There was no previous temperature excursions. No adverse effects were reported. Product quality complaint (PQC) was not reported. Additional information has been requested.
COVID arm - swollen, painful and itchy red rash that grew and spread across entire upper left arm; treated by seeing my dermatologist who prescribed Clobetasol cream which improved the symptoms.  A week later, my arm is still red but the swelling has gone down and it is no longer painful and itchy.  Note I originally received two doses of the Pfizer vaccine in March and April.  I wanted to mix and match with Moderna for the booster.  However, due to this reaction, I likely will not go with Moderna again in the future.
CD4 is the one out of whack; Horrible fatigue; Soreness in arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Lot number: ER8735) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CD4 LYMPHOCYTES ABNORMAL (non-serious), outcome "unknown", described as "CD4 is the one out of whack"; FATIGUE (non-serious), outcome "unknown", described as "Horrible fatigue"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Soreness in arm". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: He had been in touch back in 2021. He is one of the ones that had bad reaction to the Pfizer COVID 19 vaccine ER8735, expiration unknown first one he got. Seen 16 different doctors. Been with a hematologist for 6 months. CD4 is the one out of whack. Just got re-tested and it is over the 254. Since his vaccines from 2021, he is still dealing with horrible issues. Horrible fatigue.  Doctor would have to call to talk if anything can be done or anything working on this. He is a little better. There was something in one of those regarding Prednisone. They were using Prednisone to see if it might help. Make sure they both coincide with the Pfizer COVID 19 vaccine report. One of the letters said BNT162B2 on it as well. Sent list of everything he had filed. Lot ER8735 was the first one. There were many VAERs and several deaths and disabilities from that one.  He was close to death and has been fighting. He does not know of any of the individuals that had similar issues. His wife works in (hospital name withheld) and one of her colleagues had the same. He did not have any information for any others.  The 2nd Pfizer COVID 19 vaccine lot EU10150, expiration unknown. He did not get immediate symptoms after the first one. He felt something like bad allergies after the first. Soreness in arm which was fine.  His gradually got worse at weeks went on.  Regarding the Prednisone, he stopped it. He was on high alert and it just made him feel worse. He does not have a lot or expiration of the Prednisone. He confirmed he did not receive anything to send one back in. He wants to know who should his doctor call for this information and will they be able to pull up his previous reports to talk with him. Is there a separate number for a doctor to call in.
throat itching and mild throat swelling Narrative: aprox 40 mins ater vaccine,pt c/o throat itching and slight throat swelling.pt give PO 25 mg Benadryl with ease of symptoms.
Information has been received from a physician concerning a female who on 22-MAR-2007 was vaccinated with Gardasil. It was reported that the patient had injection site pain after receiving the vaccination. On 10-APR-2007, the patient called the physician's office and reported that she was still having pain in the arm and shoulder which was aggravated when raising the arm. The patient sought unspecified medical attention. At the time of the report, it was unknown if the patient recovered. This is one of two reports received from the same source. Attempts are being made to obtain identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. Upon follow-up it was reported by the physician that the patient received Gardasil, (Lot # "0011V") on 22-MAR-2007. The physician stated that after 4 weeks, the patient's injection site pain was gone. Additional information has been requested.